Home > Solutions > Interventional Specialties > Products > Diagnostic procedure trays > Safe-T™ PLUS Trays > Recommendations
Recommendations
| HealthCare Organization | Recommendation | Safe-T™ PLUS Tray Solution |
|---|---|---|
| Preventative Medical Error Reduction | ||
| The Joint Commission | 2006 National Patient Safety Goals Label all medications, medication containers, or other solutions on and off the sterile field.1 2003 National Patient Safety Goals Universal protocol to prevent wrong site, procedure or surgery, including, "Time Out" immediately before starting any surgical or invasive procedure, to conduct a final verification process to confirm the correct patient, procedure and site using active not passive communication techniques.2 |
Medication Labels & Fine Tip Marker Time Out Label |
| Sharps Safety | ||
| Centers for Disease Control & Prevention (CDC) | The CDC estimates that each year 385,000 needlesticks and other sharps-related injuries are sustained by hospital-based healthcare personnel; an average of 1,000 sharps injuries per day.3 | BD SafetyGlide™ Needles |
| National Institute for Occupational Safety and Health (NIOSH) | Sharps injury prevention devices should include either sharps disposal containers and needles or other devices with an integrated engineered sharps injury prevention feature.4 | BD Bard Parker™ Protection Disposable Scalpel |
| Occupational Safety and Health Administration (OSHA) | 2001 revision of Bloodborne Pathogens & Needlestick Prevention standards Safer needle devices that reflect technology changes to eliminate or reduce exposure to bloodborne pathogens.5 | Filter Straw® Point Lok® NeedleVISE® |
| International Sharps Injury Prevention Society (ISIPS) | Promote services and products that encompass the entire universe of safety products from modified sharps to alternative products that actually eliminate the sharp.6 | |
| Infection Prevention | ||
| Centers for Disease Control & Prevention (CDC) | The CDC recognized the "In the United States, povidone iodine has been the most widely used antiseptic for cleansing arterial catheter and CVC-insertion sites. However, in one study, preparation of central venous and arterial sites with a 2% aqueous chlorhexdine gluconate lowered BSI rates compared with site preparation with 10% povidone-iodine or 70% alcohol."8 | ChloraPrep® 3ml Applicator (Hi-Lite Orange™) |
| Institute for Healthcare Improvement (IHI) | Protecting 5 Million Lives From Harm One goal of this campaign is to help prevent CRBSIs through implementing a set of five interventions known as the "Central Line Bundle." One of these is chlorhexidine skin antisepsis.7 |
|
| Another intervention recommended by IHI is maximal barrier precautions.7 | Facial Protection | |
| Centers for Disease Control & Prevention | The CDC now recommends maximum sterile barrier precautions, including use of cap, mask, sterile gown, sterile gloves and large sterile drape during the insertion of CVCs. These substantially reduce the incidence of CRBSI.9 | |
Feedback: Corporate Communications
